Abstract:Percutaneous balloon pulmonary valvuloplasty (PBPV) is the primary treatment for pulmonary valve stenosis (PVS). The study consisted of 228 children with PVS who underwent PBPV from January 2004 to October 2019 at a single center. The risk factors for ≥moderate pulmonary regurgitation (PR), residual stenosis, and restenosis were analyzed based on the baseline patient characteristics and measured value of corresponding inspection results. Among 228 patients, follow‐up results were obtained in 193 patients. The … Show more
“…Jaing et al (22) reported that the success rate was 90%. The immediate success rate was 89.6% with Yin et al (23) . The possible cause of this difference may be due to the selection bias in our study.…”
Section: Discussionmentioning
confidence: 87%
“…This result is equivalent to that of Peterson et al (25) , who discovered the development of restenosis in 13 (14.1%) of patients who had undergone BPV; 6 individuals were re-dilated, and 7 individuals required surgery (their study involved 108 patients with a mean age of 3.6 years). According to Yin et al (23) , reported 16.6% of 193 individuals with follow-up data with residual stenosis or restenosis after initial BPV, with 9 needing reintervention.…”
Background: Pulmonary valve stenosis (PS) is a prevalent congenital heart disorder in children, and symptoms include chest distress, dyspnea, cyanosis, and heart failure in its severe criteria. Objective: To learn more about the short-term results of balloon pulmonary valvuloplasty in children who had severe pulmonary stenosis. Patients and methods: Between January 2015 and December 2018, a 4-year cross-sectional study was conducted in various centers across Egypt, with funding from the "Dar Al Orman charity". We included 146 Children varied from 5 months to 17 years of either sex diagnosed as severe pulmonary stenosis' case with doming valve with mean value of peak pressure gradient across the pulmonary valve of 74 mmHg on echocardiography. Patients were intervened with balloon-valvuloplasty. Results: There were 74 (50.7%) men and 72 (49.3%) women among the 146 patients. The average age was 5.34 (SD 0.5) years. On echocardiography, the mean pre-cath gradient via the pulmonary valve was 74.44 (SD 9.5) mmHg. The mean pressure gradient across PV was 19.54 (SD 1.9) mmHg after the intervention, (Pvalue 0.001). Before intervention, the pulmonary valve annulus on echocardiography varied from 8.5 to 20 mm, with a mean of 13.44 (SD 3.2) mm. Most patients (89%) had no complications. Only 2 (1.4%) patients had severe pulmonary valve regurgitation, and 1 (0.7%) patient had right ventricular outflow tract perforation (0.7%). Conclusion: Balloon pulmonary valvuloplasty is the preferred treatment for stenosis of the pulmonary valve in people of all ages, and it has few side effects.
“…Jaing et al (22) reported that the success rate was 90%. The immediate success rate was 89.6% with Yin et al (23) . The possible cause of this difference may be due to the selection bias in our study.…”
Section: Discussionmentioning
confidence: 87%
“…This result is equivalent to that of Peterson et al (25) , who discovered the development of restenosis in 13 (14.1%) of patients who had undergone BPV; 6 individuals were re-dilated, and 7 individuals required surgery (their study involved 108 patients with a mean age of 3.6 years). According to Yin et al (23) , reported 16.6% of 193 individuals with follow-up data with residual stenosis or restenosis after initial BPV, with 9 needing reintervention.…”
Background: Pulmonary valve stenosis (PS) is a prevalent congenital heart disorder in children, and symptoms include chest distress, dyspnea, cyanosis, and heart failure in its severe criteria. Objective: To learn more about the short-term results of balloon pulmonary valvuloplasty in children who had severe pulmonary stenosis. Patients and methods: Between January 2015 and December 2018, a 4-year cross-sectional study was conducted in various centers across Egypt, with funding from the "Dar Al Orman charity". We included 146 Children varied from 5 months to 17 years of either sex diagnosed as severe pulmonary stenosis' case with doming valve with mean value of peak pressure gradient across the pulmonary valve of 74 mmHg on echocardiography. Patients were intervened with balloon-valvuloplasty. Results: There were 74 (50.7%) men and 72 (49.3%) women among the 146 patients. The average age was 5.34 (SD 0.5) years. On echocardiography, the mean pre-cath gradient via the pulmonary valve was 74.44 (SD 9.5) mmHg. The mean pressure gradient across PV was 19.54 (SD 1.9) mmHg after the intervention, (Pvalue 0.001). Before intervention, the pulmonary valve annulus on echocardiography varied from 8.5 to 20 mm, with a mean of 13.44 (SD 3.2) mm. Most patients (89%) had no complications. Only 2 (1.4%) patients had severe pulmonary valve regurgitation, and 1 (0.7%) patient had right ventricular outflow tract perforation (0.7%). Conclusion: Balloon pulmonary valvuloplasty is the preferred treatment for stenosis of the pulmonary valve in people of all ages, and it has few side effects.
“…La estenosis pulmonar es una cardiopatía congénita acianótica que representa, aproximadamente, 8 a 10% de los defectos cardiacos al nacimiento 1 , 2 . Su presentación puede ser asintomática, con un hallazgo incidental de un soplo, o de grado severo con cianosis, dolor torácico, disnea y falla cardiaca 3 - 5 .…”
Objetivo. Evaluar la efectividad de la valvuloplastia percutánea con balón (VPB) en estenosis valvular pulmonar (EP) en pediatría y sus resultados durante el seguimiento. Métodos. Se estudiaron 80 pacientes con EP a quienes se les realizaron VPB entre enero de 2014 y diciembre de 2019. Las características demográficas, ecocardiográficas y hemodinámicas del procedimiento se detallan a través de una estadística descriptiva en tanto que en el seguimiento se utilizó pruebas estadísticas paramétricas y no paramétricas con relación a insuficiencia pulmonar y reestenosis. Resultados. El rango de edad fue de 2 años (rango intercuartil RIQ 10,5 - 72 meses), el sexo predominante fue masculino con 56,2%. La gradiente transvalvular pulmonar disminuyó de 61,7 ± 21,2 mmHg a 17 mmHg (RIQ: 11 - 26 mmHg). La tasa de éxito inmediato de la VPB se situó en el 90%. La mediana del tiempo de seguimiento fue de 21 meses (RIQ: 5-47,5 meses). Todos los pacientes en el seguimiento mostraron algún grado de insuficiencia pulmonar en cada punto de corte, en el 17% de los casos al final de su seguimiento se encontró insuficiencia severa. Se encontró tres casos de reestenosis a largo plazo (3,8%) y 6 casos (7,5%) que ingresaron a sala de operaciones para plastia o recambio valvular pulmonar. Las complicaciones reportadas alcanzaron 10% de casos, de los cuales dos pacientes ingresaron a cirugía durante el procedimiento por complicaciones mayores. Se encontró asociación significativa con insuficiencia pulmonar severa al final del seguimiento y la relación anillo/balón. Conclusiones. La VPB es una técnica efectiva en el tratamiento de la estenosis valvular pulmonar, con complicaciones reportadas, pero con buenos resultados durante el seguimiento.
“…3 Studies have described percutaneous balloon valvuloplasty to have immediate success with reintervention requirement in fewer cases along with reasonable growth of the RV and that of the pulmonary valve in infants with critical pulmonary valve stenosis. 4,5 However, the procedure often presents technical difficulties because of increased pressure in the RV making it difficult to reach the stenotic pulmonary valve. To overcome this issue certain methods have been devised and used around the world like using a catheter with bent hard end of a guide wire and using trans-jugular approach instead of the routinely used femoral vein.…”
Critical congenital pulmonary stenosis with intact interventricular septum is a cyanotic and potentially lethal neonatal cardiac anomaly. Percutaneous transcatheter balloon pulmonary valvuloplasty for critical pulmonary stenosis often presents technical difficulties due to supra-systemic pressure in right ventricle. Using transjugular approach instead of the femoral vein helps in dealing with this issue. We describe the successful use of right internal jugular vein approach in a case of critical pulmonary stenosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.